| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |